Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. more
Time Frame | RDY | Sector | S&P500 |
---|---|---|---|
1-Week Return | 5.45% | -0.94% | -2.6% |
1-Month Return | 8.17% | -5.08% | -1.08% |
3-Month Return | -2.41% | -10.62% | 3.45% |
6-Month Return | 7.44% | -6.18% | 8.57% |
1-Year Return | 15.12% | 1.98% | 24.3% |
3-Year Return | 23.35% | -0.93% | 25.58% |
5-Year Return | 89.87% | 33.84% | 84.07% |
10-Year Return | 55.9% | 102.52% | 185.12% |
Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 174.60B | 189.72B | 214.39B | 245.88B | 279.16B | [{"date":"2020-03-31","value":62.54,"profit":true},{"date":"2021-03-31","value":67.96,"profit":true},{"date":"2022-03-31","value":76.8,"profit":true},{"date":"2023-03-31","value":88.08,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Cost of Revenue | 80.59B | 86.64B | 100.55B | 42.91B | 115.56B | [{"date":"2020-03-31","value":69.74,"profit":true},{"date":"2021-03-31","value":74.98,"profit":true},{"date":"2022-03-31","value":87.01,"profit":true},{"date":"2023-03-31","value":37.13,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Gross Profit | 94.01B | 103.08B | 113.84B | 202.97B | 163.61B | [{"date":"2020-03-31","value":46.32,"profit":true},{"date":"2021-03-31","value":50.78,"profit":true},{"date":"2022-03-31","value":56.09,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":80.61,"profit":true}] |
Gross Margin | 53.84% | 54.33% | 53.10% | 82.55% | 58.61% | [{"date":"2020-03-31","value":65.22,"profit":true},{"date":"2021-03-31","value":65.82,"profit":true},{"date":"2022-03-31","value":64.32,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":71,"profit":true}] |
Operating Expenses | 61.25B | 70.12B | 76.80B | 117.61B | 95.88B | [{"date":"2020-03-31","value":52.08,"profit":true},{"date":"2021-03-31","value":59.62,"profit":true},{"date":"2022-03-31","value":65.3,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":81.52,"profit":true}] |
Operating Income | 37.05B | 36.06B | 40.82B | 96.28B | 67.73B | [{"date":"2020-03-31","value":38.49,"profit":true},{"date":"2021-03-31","value":37.45,"profit":true},{"date":"2022-03-31","value":42.39,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":70.34,"profit":true}] |
Total Non-Operating Income/Expense | (19.11B) | 5.70B | 4.94B | 1.91B | 4.71B | [{"date":"2020-03-31","value":-335.49,"profit":false},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":86.73,"profit":true},{"date":"2023-03-31","value":33.58,"profit":true},{"date":"2024-03-31","value":82.64,"profit":true}] |
Pre-Tax Income | 18.03B | 28.32B | 32.30B | 60.48B | 71.87B | [{"date":"2020-03-31","value":25.09,"profit":true},{"date":"2021-03-31","value":39.41,"profit":true},{"date":"2022-03-31","value":44.94,"profit":true},{"date":"2023-03-31","value":84.16,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Income Taxes | (1.47B) | 9.18B | 8.73B | 15.41B | 16.19B | [{"date":"2020-03-31","value":-9.06,"profit":false},{"date":"2021-03-31","value":56.68,"profit":true},{"date":"2022-03-31","value":53.94,"profit":true},{"date":"2023-03-31","value":95.22,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Income After Taxes | 19.50B | 19.15B | 23.57B | 45.07B | 55.68B | [{"date":"2020-03-31","value":35.02,"profit":true},{"date":"2021-03-31","value":34.39,"profit":true},{"date":"2022-03-31","value":42.32,"profit":true},{"date":"2023-03-31","value":80.94,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Income From Continuous Operations | 19.50B | 19.15B | 23.57B | 45.07B | 55.68B | [{"date":"2020-03-31","value":35.02,"profit":true},{"date":"2021-03-31","value":34.39,"profit":true},{"date":"2022-03-31","value":42.32,"profit":true},{"date":"2023-03-31","value":80.94,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Net Income | 19.50B | 17.24B | 23.57B | 45.07B | 55.68B | [{"date":"2020-03-31","value":35.02,"profit":true},{"date":"2021-03-31","value":30.96,"profit":true},{"date":"2022-03-31","value":42.32,"profit":true},{"date":"2023-03-31","value":80.93,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
EPS (Diluted) | 2.76 | 1.56 | 1.92 | 3.33 | 251.10 | [{"date":"2020-03-31","value":1.1,"profit":true},{"date":"2021-03-31","value":0.62,"profit":true},{"date":"2022-03-31","value":0.76,"profit":true},{"date":"2023-03-31","value":1.33,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
RDY | |
---|---|
Cash Ratio | 0.49 |
Current Ratio | 1.92 |
Quick Ratio | 1.36 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RDY | |
---|---|
ROA (LTM) | 10.40% |
ROE (LTM) | 19.27% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RDY | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.34 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.66 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RDY | |
---|---|
Trailing PE | 19.71 |
Forward PE | 19.12 |
P/S (TTM) | 0.04 |
P/B | 3.56 |
Price/FCF | 9 |
EV/R | 3.68 |
EV/Ebitda | 12.28 |
PEG | 4.51 |
Dr. Reddy’s Laboratories Ltd ADR (RDY) share price today is $15.49
Yes, Indians can buy shares of Dr. Reddy’s Laboratories Ltd ADR (RDY) on Vested. To buy Dr. Reddy’s Laboratories Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RDY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Dr. Reddy’s Laboratories Ltd ADR (RDY) via the Vested app. You can start investing in Dr. Reddy’s Laboratories Ltd ADR (RDY) with a minimum investment of $1.
You can invest in shares of Dr. Reddy’s Laboratories Ltd ADR (RDY) via Vested in three simple steps:
The 52-week high price of Dr. Reddy’s Laboratories Ltd ADR (RDY) is $16.89. The 52-week low price of Dr. Reddy’s Laboratories Ltd ADR (RDY) is $12.63.
The price-to-earnings (P/E) ratio of Dr. Reddy’s Laboratories Ltd ADR (RDY) is 19.7051
The price-to-book (P/B) ratio of Dr. Reddy’s Laboratories Ltd ADR (RDY) is 3.56
The dividend yield of Dr. Reddy’s Laboratories Ltd ADR (RDY) is 0.62%
The market capitalization of Dr. Reddy’s Laboratories Ltd ADR (RDY) is $13.11B
The stock symbol (or ticker) of Dr. Reddy’s Laboratories Ltd ADR is RDY